Britannia Pharmaceuticals Ltd is a small UK company that has spent years developing our medicine and making them as safely administered and effective as currently possible. For over 20 years Britannia has made our medicines available to ever increasing numbers of patients around the world. We achieve this by knowing the value of international partnerships - a partner company’s regional knowledge means a better understanding of the local market.  We have over 19 international partner companies covering over 40 countries to date (click here for a current list).

If your territory is not yet served by our products and you have an interest in working with us to enter this market please contact us.

Britannia seeks to bring new products to market within the field of neurology. Of especial interest to Britannia are technologies that fulfil a niche unmet medical need. We are happy to consider technologies at all stages of the commercial development lifecycle whether you are a/represent:

- Academic researcher(s) or institution(s)
- Biotechnology company
- Pharmaceutical company

Where you have technologies available to license we are interested to receive your non-confidential information in the first instance.

When considering new partners in product licensing we identify what each company brings to a deal. This allows us both to more sensitively assess what each party brings to the commercial arrangement.

For further information please email info@britannia-pharm.com and one of our Business Development Team will contact you.